SCHEMBL21416718

SCHEMBL21416718

CNC(=O)c1ccc(OC)c(N=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 2/20 0.50
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ CCNC P24863 1/20 0.45
▸ CDK8 P49336 1/20 0.45
▸ CYP1A2 P05177 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PYGL P06737 1/20 0.43
▸ TSHR P16473 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24422981 0.83 MAPT (0.58) ALDH1A1HPGDCYP1A2CYP3A4MAPT
SCHEMBL13219859 0.81 CA12 (0.65) ALDH1A1CYP1A2CYP3A4MAPTCYP2C9
SCHEMBL13219861 0.81 ALDH1A1 (0.51) ALDH1A1HPGDCYP1A2CYP3A4MAPT
SCHEMBL4151619 0.81 CYP1A2 (0.66) PLK1ALDH1A1HPGDCCNCCDK8
SCHEMBL14879295 0.80 TSHR (0.46) ALDH1A1CYP1A2CYP3A4MAPTCYP2C9
SCHEMBL19519009 0.78 PDE4D (0.60) PLK1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL12062652 0.78 TAS1R3 (0.60) PLK1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL30997032 0.78 NEU3 (0.56) PLK1HPGDPYGLTSHRSMN1; SMN2
SCHEMBL7984450 0.77 LMNA (0.67) PLK1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL22516365 0.77 PLK1 (0.53) PLK1SLC6A2SLC6A4SLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 — — EP disclosed
Send feedback